{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:31:48Z","timestamp":1786991508966,"version":"build-2736575974"},"reference-count":114,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.jaut.2025.103397","type":"journal-article","created":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T07:44:32Z","timestamp":1741938272000},"page":"103397","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Advanced pulmonary sarcoidosis"],"prefix":"10.1016","volume":"152","author":[{"given":"Florence","family":"Jeny","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Valeyre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elyse E.","family":"Lower","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4871-3862","authenticated-orcid":false,"given":"Robert P.","family":"Baughman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10 Pt 1","key":"10.1016\/j.jaut.2025.103397_bib1","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1164\/ajrccm.164.10.2104046","article-title":"Clinical characteristics of patients in a case control study of sarcoidosis","volume":"164","author":"Baughman","year":"2001","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"2","key":"10.1016\/j.jaut.2025.103397_bib2","first-page":"178","article-title":"Clinical findings in 715 patients with newly detected pulmonary sarcoidosis--results of a cooperative study in former West Germany and Switzerland","volume":"15","author":"Loddenkemper","year":"1998","journal-title":"WATL Study Group. Wissenschaftliche Arbeitsgemeinschaft fur die Therapie von Lungenkrankheitan. Sarcoidosis Vasc Diffuse Lung Dis."},{"key":"10.1016\/j.jaut.2025.103397_bib3","first-page":"158","article-title":"The prognosis of sarcoidosis in Finland and Hokkaido, Japan. A comparative five-year study of biopsy-proven cases","volume":"17","author":"Pietinalho","year":"2000","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"issue":"9923","key":"10.1016\/j.jaut.2025.103397_bib4","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/S0140-6736(13)60680-7","article-title":"Sarcoidosis","volume":"383","author":"Valeyre","year":"2014","journal-title":"Lancet."},{"issue":"5","key":"10.1016\/j.jaut.2025.103397_bib5","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1164\/rccm.202106-1366CI","article-title":"Management of advanced pulmonary sarcoidosis","volume":"205","author":"Gupta","year":"2022","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.jaut.2025.103397_bib6","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1164\/rccm.201006-0865CI","article-title":"A concise review of pulmonary sarcoidosis","volume":"183","author":"Baughman","year":"2011","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"11","key":"10.1016\/j.jaut.2025.103397_bib7","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1136\/thx.2006.062836","article-title":"Incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UK","volume":"61","author":"Gribbin","year":"2006","journal-title":"Thorax"},{"issue":"2","key":"10.1016\/j.jaut.2025.103397_bib8","doi-asserted-by":"crossref","first-page":"51\/2","DOI":"10.1183\/13993003.01815-2017","article-title":"Sarcoidosis mortality in Sweden: a population-based cohort study","volume":"51","author":"Rossides","year":"2018","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.jaut.2025.103397_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2021.106548","article-title":"Sarcoidosis: a nationwide registry-based study of incidence, prevalence and diagnostic work-up","volume":"187","author":"Sikjaer","year":"2021","journal-title":"Respir. Med."},{"key":"10.1016\/j.jaut.2025.103397_bib10","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.rmed.2018.10.004","article-title":"Sarcoidosis: A benign disease or a culture of neglect?","volume":"144S","author":"Wells","year":"2018","journal-title":"Respir. Med."},{"issue":"11","key":"10.1016\/j.jaut.2025.103397_bib11","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1164\/rccm.201010-1679OC","article-title":"Sarcoidosis-related mortality in the United States from 1988 to 2007","volume":"183","author":"Swigris","year":"2011","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"6","key":"10.1016\/j.jaut.2025.103397_bib12","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1183\/13993003.00457-2016","article-title":"Sarcoidosis-related mortality in France: a multiple-cause-of-death analysis","volume":"48","author":"Jamilloux","year":"2016","journal-title":"Eur. Respir. J."},{"issue":"3","key":"10.1016\/j.jaut.2025.103397_bib13","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.rmed.2005.06.013","article-title":"Prognostic factors and causes of death in Korean patients with idiopathic pulmonary fibrosis","volume":"100","author":"Jeon","year":"2006","journal-title":"Respir. Med."},{"issue":"1","key":"10.1016\/j.jaut.2025.103397_bib14","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.chest.2021.07.2166","article-title":"National temporal trends in hospitalization and inpatient mortality in patients with pulmonary sarcoidosis in the United States between 2007 and 2018","volume":"161","author":"Alqalyoobi","year":"2022","journal-title":"Chest"},{"key":"10.1016\/j.jaut.2025.103397_bib15","first-page":"10","article-title":"Racial difference in sarcoidosis mortality in the United States","author":"Mirsaeidi","year":"2014","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.jaut.2025.103397_bib16","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0002-9343(97)89518-6","article-title":"Sarcoidosis mortality in the United States 1979-1991: an analysis of multiple-cause mortality data","volume":"100","author":"Gideon","year":"1996","journal-title":"Am. J. Med."},{"key":"10.1016\/j.jaut.2025.103397_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2022.106828","article-title":"Trends in sarcoidosis mortality rate in Japan from 2001 to 2020: a population-based study","volume":"196","author":"Harada","year":"2022","journal-title":"Respir. Med."},{"key":"10.1016\/j.jaut.2025.103397_bib18","first-page":"154","article-title":"Predicting respiratory failure in sarcoidosis patients","volume":"14","author":"Baughman","year":"1997","journal-title":"Sarcoidosis"},{"key":"10.1016\/j.jaut.2025.103397_bib19","first-page":"248","article-title":"Racial differences in cardiac sarcoidosis incidence observed at autopsy","volume":"11","author":"Iwai","year":"1994","journal-title":"Sarcoidosis"},{"issue":"2","key":"10.1016\/j.jaut.2025.103397_bib20","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S2213-2600(13)70276-5","article-title":"An integrated clinicoradiological staging system for pulmonary sarcoidosis: a case-cohort study","volume":"2","author":"Walsh","year":"2014","journal-title":"Lancet Respir. Med."},{"issue":"1","key":"10.1016\/j.jaut.2025.103397_bib21","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.chest.2017.07.008","article-title":"Predictors of mortality in pulmonary sarcoidosis","volume":"153","author":"Kirkil","year":"2018","journal-title":"Chest"},{"key":"10.1016\/j.jaut.2025.103397_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2020.105997","article-title":"Predictors of mortality in fibrosing pulmonary sarcoidosis","volume":"169","author":"Jeny","year":"2020","journal-title":"Respir. Med."},{"key":"10.1016\/j.jaut.2025.103397_bib23","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.chest.2023.10.021","article-title":"HRCT fibrotic patterns in stage 4 pulmonary sarcoidosis: Impact on pulmonary function and survival","volume":"165","author":"Obi","year":"2024","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.jaut.2025.103397_bib24","doi-asserted-by":"crossref","first-page":"49\/6","DOI":"10.1183\/13993003.02396-2016","article-title":"Chronic pulmonary aspergillosis complicating sarcoidosis","volume":"49","author":"Uzunhan","year":"2017","journal-title":"Eur. Respir. J."},{"issue":"49","key":"10.1016\/j.jaut.2025.103397_bib25","article-title":"Severe infections in sarcoidosis: incidence, predictors and long-term outcome in a cohort of 585 patients","volume":"96","author":"Dureault","year":"2017","journal-title":"Medicine (Baltim.)"},{"key":"10.1016\/j.jaut.2025.103397_bib26","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1093\/qjmed\/hci073","article-title":"Fungal infections as a complication of therapy for sarcoidosis","volume":"98","author":"Baughman","year":"2005","journal-title":"QJM."},{"issue":"5","key":"10.1016\/j.jaut.2025.103397_bib27","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1097\/MCP.0000000000000806","article-title":"Sarcoidosis and maligancy: the chicken and the egg?","volume":"27","author":"Bonifazi","year":"2021","journal-title":"Curr. Opin. Pulm. Med."},{"issue":"3","key":"10.1016\/j.jaut.2025.103397_bib28","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1378\/chest.14-1475","article-title":"Sarcoidosis and cancer risk: systematic review and meta-analysis of observational studies","volume":"147","author":"Bonifazi","year":"2015","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.jaut.2025.103397_bib29","doi-asserted-by":"crossref","first-page":"13993003","DOI":"10.1183\/13993003.01290-2016","article-title":"Risk of cardiovascular disease among patients with sarcoidosis: a population-based retrospective cohort study, 1976-2013","volume":"49","author":"Ungprasert","year":"2017","journal-title":"Eur. Respir. J."},{"issue":"2","key":"10.1016\/j.jaut.2025.103397_bib30","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/art.38210","article-title":"Glucocorticoid dose thresholds associated with all-cause and cardiovascular mortality in rheumatoid arthritis","volume":"66","author":"del Rincon","year":"2014","journal-title":"Arthritis Rheumatol."},{"issue":"12","key":"10.1016\/j.jaut.2025.103397_bib31","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1016\/j.mayocp.2017.09.015","article-title":"Increased risk of multimorbidity in patients with sarcoidosis: A population-based cohort study 1976 to 2013","volume":"92","author":"Ungprasert","year":"2017","journal-title":"Mayo Clin. Proc."},{"issue":"21","key":"10.1016\/j.jaut.2025.103397_bib32","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10215067","article-title":"The association between sarcoidosis and ischemic heart disease-A healthcare analysis of a large Israeli population","volume":"10","author":"Gonen","year":"2021","journal-title":"J. Clin. Med."},{"issue":"6","key":"10.1016\/j.jaut.2025.103397_bib33","doi-asserted-by":"crossref","first-page":"2004079","DOI":"10.1183\/13993003.04079-2020","article-title":"ERS clinical practice guidelines on treatment of sarcoidosis","volume":"58","author":"Baughman","year":"2021","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.jaut.2025.103397_bib34","first-page":"209","article-title":"Clinical characteristics of sarcoidosis patients in the United States versus China","volume":"34","author":"Zhou","year":"2017","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"issue":"5","key":"10.1016\/j.jaut.2025.103397_bib35","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S2213-2600(23)00267-9","article-title":"High-resolution CT phenotypes in pulmonary sarcoidosis: a multinational Delphi consensus study","volume":"12","author":"Desai","year":"2023","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.jaut.2025.103397_bib36","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/j.rmed.2018.08.008","article-title":"Sarcoidosis and IPF in the same patient-a coincidence, an association or a phenotype?","volume":"144S","author":"Collins","year":"2018","journal-title":"Respir. Med."},{"issue":"2","key":"10.1016\/j.jaut.2025.103397_bib37","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1378\/chest.15-0615","article-title":"Histopathology of explanted lungs from patients with a diagnosis of pulmonary sarcoidosis","volume":"149","author":"Zhang","year":"2016","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.jaut.2025.103397_bib38","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/s12931-022-02094-7","article-title":"Characterization of the PF-ILD phenotype in patients with advanced pulmonary sarcoidosis","volume":"23","author":"Schimmelpennink","year":"2022","journal-title":"Respir. Res."},{"issue":"5","key":"10.1016\/j.jaut.2025.103397_bib39","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S2213-2600(20)30036-9","article-title":"Nintedanib in patients with progressive fibrosing interstitial lung diseases-subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial","volume":"8","author":"Wells","year":"2020","journal-title":"Lancet Respir. Med."},{"issue":"1","key":"10.1016\/j.jaut.2025.103397_bib40","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00529-2023","article-title":"Real-world experience of nintedanib for progressive fibrosing interstitial lung disease in the UK","volume":"10","author":"Dixon","year":"2024","journal-title":"ERJ Open Res"},{"issue":"11","key":"10.1016\/j.jaut.2025.103397_bib41","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1164\/rccm.200706-877OC","article-title":"Interstitial lung disease in systemic sclerosis: a simple staging system","volume":"177","author":"Goh","year":"2008","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"7","key":"10.1016\/j.jaut.2025.103397_bib42","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1164\/rccm.2111053","article-title":"Idiopathic pulmonary fibrosis: a composite physiologic index derived from disease extent observed by computed tomography","volume":"167","author":"Wells","year":"2003","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"5","key":"10.1016\/j.jaut.2025.103397_bib43","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1378\/chest.116.5.1194","article-title":"Airway obstruction in bronchial sarcoidosis: outcome with treatment","volume":"116","author":"Lavergne","year":"1999","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.jaut.2025.103397_bib44","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1097\/RCT.0b013e31815b63dd","article-title":"High-resolution computed tomographic imaging of airways in sarcoidosis patients with airflow obstruction","volume":"32","author":"Naccache","year":"2008","journal-title":"J. Comput. Assist. Tomogr."},{"issue":"2","key":"10.1016\/j.jaut.2025.103397_bib45","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1378\/chest.127.2.472","article-title":"Endoluminal stenosis of proximal bronchi in sarcoidosis: bronchoscopy, function, and evolution","volume":"127","author":"Chambellan","year":"2005","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.jaut.2025.103397_bib46","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1016\/j.chest.2020.04.074","article-title":"Mixed ventilatory defects in pulmonary sarcoidosis: prevalence and clinical features","volume":"158","author":"Kouranos","year":"2020","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.jaut.2025.103397_bib47","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.03358-2020","article-title":"Lung transplantation for sarcoidosis: outcome and prognostic factors","volume":"58","author":"Le Pavec","year":"2021","journal-title":"Eur. Respir. J."},{"issue":"2","key":"10.1016\/j.jaut.2025.103397_bib48","article-title":"Value of pulmonary function testing identifying progressive pulmonary disease in fibrotic sarcoidosis: results of a prospective feasibility study","volume":"39","author":"Baughman","year":"2022","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"key":"10.1016\/j.jaut.2025.103397_bib49","article-title":"Nintedanib in progressive fibrosing interstitial lung diseases","volume":"10","author":"Flaherty","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.jaut.2025.103397_bib50","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1183\/09031936.00187410","article-title":"Stage IV sarcoidosis: comparison of survival with the general population and causes of death","volume":"38","author":"Nardi","year":"2011","journal-title":"Eur. Respir. J."},{"issue":"12","key":"10.1016\/j.jaut.2025.103397_bib51","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1016\/j.rmed.2011.08.012","article-title":"Inflammatory activity assessment by F18 FDG-PET\/CT in persistent symptomatic sarcoidosis","volume":"105","author":"Mostard","year":"2011","journal-title":"Respir. Med."},{"issue":"4","key":"10.1016\/j.jaut.2025.103397_bib52","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1183\/13993003.01032-2015","volume":"46","author":"Galie","year":"2015","journal-title":"Eur. Respir. J."},{"issue":"163","key":"10.1016\/j.jaut.2025.103397_bib53","doi-asserted-by":"crossref","first-page":"210165","DOI":"10.1183\/16000617.0165-2021","article-title":"WASOG statement on the diagnosis and management of sarcoidosis-associated pulmonary hypertension","volume":"31","author":"Savale","year":"2022","journal-title":"Eur. Respir. Rev."},{"issue":"12","key":"10.1016\/j.jaut.2025.103397_bib54","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1002\/ejhf.3057","article-title":"Predictors of outcome in a contemporary cardiac sarcoidosis population: role of brain natriuretic peptide, left ventricular function and myocardial inflammation","volume":"25","author":"Kouranos","year":"2023","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.jaut.2025.103397_bib55","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1378\/chest.09-2002","article-title":"Survival in sarcoidosis associated pulmonary hypertension: the importance of hemodynamic evaluation","volume":"138","author":"Baughman","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.jaut.2025.103397_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2022.106801","article-title":"The six-minute walk test in sarcoidosis associated pulmonary hypertension: results from an international registry","volume":"196","author":"Gupta","year":"2022","journal-title":"Respir. Med."},{"issue":"5","key":"10.1016\/j.jaut.2025.103397_bib57","doi-asserted-by":"crossref","first-page":"1901747","DOI":"10.1183\/13993003.01747-2019","article-title":"Physiological predictors of survival in patients with sarcoidosis-associated pulmonary hypertension: results from an international registry","volume":"55","author":"Shlobin","year":"2020","journal-title":"Eur. Respir. J."},{"issue":"4","key":"10.1016\/j.jaut.2025.103397_bib58","doi-asserted-by":"crossref","DOI":"10.1002\/pul2.12297","article-title":"Pulmonary hemodynamics and transplant-free survival in sarcoidosis-associated pulmonary hypertension: results from an international registry","volume":"13","author":"Gayen","year":"2023","journal-title":"Pulm. Circ."},{"issue":"8","key":"10.1016\/j.jaut.2025.103397_bib59","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1164\/rccm.202002-0251ST","article-title":"Diagnosis and detection of sarcoidosis. An official American thoracic society clinical practice guideline","volume":"201","author":"Crouser","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"4","key":"10.1016\/j.jaut.2025.103397_bib60","article-title":"Echocardiographic estimate of pulmonary artery pressure in sarcoidosis patients - real world data from a multi-national study","volume":"38","author":"Huitema","year":"2022","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"key":"10.1016\/j.jaut.2025.103397_bib61","first-page":"108","article-title":"Pulmonary hypertension in sarcoidosis","volume":"23","author":"Baughman","year":"2006","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"issue":"1","key":"10.1016\/j.jaut.2025.103397_bib62","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1136\/thx.2005.042838","article-title":"Pulmonary hypertension associated with sarcoidosis: mechanisms, haemodynamics and prognosis","volume":"61","author":"Nunes","year":"2006","journal-title":"Thorax"},{"issue":"4","key":"10.1016\/j.jaut.2025.103397_bib63","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1055\/s-0037-1603767","article-title":"Sarcoidosis-associated pulmonary hypertension","volume":"38","author":"Shlobin","year":"2017","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"10.1016\/j.jaut.2025.103397_bib64","article-title":"Prognostic impact of venous thromboembolism on the course of sarcoidosis: a multicenter retrospective case-control study","volume":"84","author":"Taieb","year":"2023","journal-title":"Respir Med Res"},{"issue":"4","key":"10.1016\/j.jaut.2025.103397_bib65","first-page":"50\/4","article-title":"Management and long-term outcomes of sarcoidosis-associated pulmonary hypertension","volume":"50","author":"Boucly","year":"201719","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.jaut.2025.103397_bib66","article-title":"Interventional therapy in sarcoidosis-associated pulmonary arterial stenosis and pulmonary hypertension","volume":"10","author":"Liu","year":"2015","journal-title":"Clin Respir J"},{"issue":"3","key":"10.1016\/j.jaut.2025.103397_bib67","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.healun.2007.11.576","article-title":"Pulmonary hypertension in end-stage pulmonary sarcoidosis: therapeutic effect of sildenafil?","volume":"27","author":"Milman","year":"2008","journal-title":"J. Heart Lung Transplant."},{"issue":"1","key":"10.1016\/j.jaut.2025.103397_bib68","first-page":"74","article-title":"Safety of macitentan in sarcoidosis-associated pulmonary hypertension: a case-series","volume":"37","author":"Mathijssen","year":"2020","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"key":"10.1016\/j.jaut.2025.103397_bib69","first-page":"110","article-title":"Inhaled iloprost for sarcoidosis associated pulmonary hypertension","volume":"26","author":"Baughman","year":"2009","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"issue":"4","key":"10.1016\/j.jaut.2025.103397_bib70","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1086\/688775","article-title":"Tadalafil therapy for sarcoidosis-associated pulmonary hypertension","volume":"6","author":"Ford","year":"2016","journal-title":"Pulm. Circ."},{"issue":"2","key":"10.1016\/j.jaut.2025.103397_bib71","first-page":"139","article-title":"Ambrisentan for sarcoidosis associated pulmonary hypertension","volume":"28","author":"Judson","year":"2011","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"key":"10.1016\/j.jaut.2025.103397_bib72","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1378\/chest.08-1881","article-title":"Treatment of sarcoidosis-associated pulmonary hypertension: A two-center experience","volume":"135","author":"Barnett","year":"2009","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.jaut.2025.103397_bib73","first-page":"82","article-title":"Treatment of sarcoidosis-associated pulmonary hypertension: a single centre retrospective experience using targeted therapies","volume":"31","author":"Keir","year":"2014","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"key":"10.1016\/j.jaut.2025.103397_bib74","first-page":"10","article-title":"Bosentan for sarcoidosis associated pulmonary hypertension: a double-blind placebo controlled randomized trial","author":"Baughman","year":"2013","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.jaut.2025.103397_bib75","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.chest.2021.07.2162","article-title":"Riociguat for sarcoidosis-associated pulmonary hypertension: Results of a 1-year double-blind, placebo-controlled trial","volume":"161","author":"Baughman","year":"2022","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.jaut.2025.103397_bib76","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1183\/23120541.00094-2019","article-title":"Results of the standard set for pulmonary sarcoidosis: feasibility and multicentre outcomes","volume":"5","author":"Kampstra","year":"2019","journal-title":"ERJ Open Res"},{"issue":"1","key":"10.1016\/j.jaut.2025.103397_bib77","article-title":"Clinical characteristics and outcomes of Korean patients with sarcoidosis","volume":"11","author":"Kim","year":"2021","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.jaut.2025.103397_bib78","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1513\/AnnalsATS.202204-328OC","article-title":"Heterogeneity of lung function phenotypes in sarcoidosis: role of race and sex differences","volume":"20","author":"Sharp","year":"2023","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.jaut.2025.103397_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2021.106564","article-title":"The impact of demographic disparities in the presentation of sarcoidosis: a multicenter prospective study","volume":"187","author":"Zhou","year":"2021","journal-title":"Respir. Med."},{"issue":"8","key":"10.1016\/j.jaut.2025.103397_bib80","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1164\/rccm.201906-1250OC","article-title":"Income and other contributors to poor outcomes in U.S. Patients with sarcoidosis","volume":"201","author":"Harper","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"5","key":"10.1016\/j.jaut.2025.103397_bib81","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1097\/MCP.0000000000000704","article-title":"Socioeconomic determinants and disparities in sarcoidosis","volume":"26","author":"Sharp","year":"2020","journal-title":"Curr. Opin. Pulm. Med."},{"issue":"4","key":"10.1016\/j.jaut.2025.103397_bib82","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00357-2022","article-title":"Neighbourhood disadvantage impacts on pulmonary function in patients with sarcoidosis","volume":"8","author":"Goobie","year":"2022","journal-title":"ERJ Open Res"},{"issue":"1","key":"10.1016\/j.jaut.2025.103397_bib83","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1378\/chest.12-2479","article-title":"Accuracy of individual variables in the monitoring of long-term change in pulmonary sarcoidosis as judged by serial high-resolution CT scan data","volume":"145","author":"Zappala","year":"2014","journal-title":"Chest"},{"key":"10.1016\/j.jaut.2025.103397_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2021.106371","article-title":"Antifibrotic drugs for pulmonary sarcoidosis: a treatment in search of an indication","volume":"180","author":"Judson","year":"2021","journal-title":"Respir. Med."},{"issue":"6","key":"10.1016\/j.jaut.2025.103397_bib85","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01482-2018","article-title":"Dramatic response of refractory sarcoidosis under ruxolitinib in a patient with associated JAK2-mutated polycythemia","volume":"52","author":"Rotenberg","year":"2018","journal-title":"Eur. Respir. J."},{"issue":"5","key":"10.1016\/j.jaut.2025.103397_bib86","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S2213-2600(18)30064-X","article-title":"Pulmonary sarcoidosis","volume":"6","author":"Spagnolo","year":"2018","journal-title":"Lancet Respir. Med."},{"issue":"2","key":"10.1016\/j.jaut.2025.103397_bib87","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1148\/radiology.182.2.1732948","article-title":"Pulmonary sarcoidosis: CT assessment of lesion reversibility","volume":"182","author":"Brauner","year":"1992","journal-title":"Radiology"},{"issue":"12","key":"10.1016\/j.jaut.2025.103397_bib88","first-page":"10","article-title":"Severity of pulmonary involvement and (18)F-FDG PET activity in sarcoidosis","author":"Mostard","year":"2012","journal-title":"Respir. Med."},{"issue":"3","key":"10.1016\/j.jaut.2025.103397_bib89","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1183\/09031936.00088612","article-title":"Imaging the inflammatory activity of sarcoidosis","volume":"41","author":"Keijsers","year":"2013","journal-title":"Eur. Respir. J."},{"issue":"2","key":"10.1016\/j.jaut.2025.103397_bib90","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/CPM.0000000000000136","article-title":"Refractory pulmonary sarcoidosis - proposal of a definition and recommendations for the diagnostic and therapeutic approach","volume":"23","author":"Korsten","year":"2016","journal-title":"Clin. Pulm. Med."},{"issue":"7","key":"10.1016\/j.jaut.2025.103397_bib91","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1136\/thorax.57.7.655","article-title":"Pulmonary sarcoidosis and the acute respiratory distress syndrome (ARDS)","volume":"57","author":"Sabbagh","year":"2002","journal-title":"Thorax"},{"key":"10.1016\/j.jaut.2025.103397_bib92","article-title":"Acute alveolar sarcoidosis presenting with hypoxaemic respiratory failure","volume":"2014","author":"Gera","year":"2014","journal-title":"BMJ Case Rep."},{"issue":"18","key":"10.1016\/j.jaut.2025.103397_bib93","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.2169\/internalmedicine.4624-20","article-title":"Pulmonary sarcoidosis presenting with acute respiratory failure: a report of a case diagnosed by endobronchial ultrasound-guided transbronchial needle aspiration on ventilation after intubation","volume":"59","author":"Taniguchi","year":"2020","journal-title":"Intern Med"},{"issue":"11","key":"10.1016\/j.jaut.2025.103397_bib94","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.4187\/respcare.01174","article-title":"Acute hypoxemic respiratory failure in sarcoidosis: a case report and literature review","volume":"56","author":"Gupta","year":"2011","journal-title":"Respir. Care"},{"issue":"4","key":"10.1016\/j.jaut.2025.103397_bib95","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1378\/chest.12-1060","article-title":"Acute pulmonary exacerbations of sarcoidosis","volume":"142","author":"Panselinas","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.jaut.2025.103397_bib96","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1016\/j.rmed.2013.10.014","article-title":"Frequency of acute worsening events in fibrotic pulmonary sarcoidosis patients","volume":"107","author":"Baughman","year":"2013","journal-title":"Respir. Med."},{"issue":"3","key":"10.1016\/j.jaut.2025.103397_bib97","article-title":"Roflumilast (Daliresp\u00ae) to reduce acute pulmonary events in fibrotic sarcoidosis: a multi-center, double blind, placebo controlled, randomized clinical trial","volume":"38","author":"Baughman","year":"2021","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"issue":"3","key":"10.1016\/j.jaut.2025.103397_bib98","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00767-2020","article-title":"Risk of first and recurrent serious infection in sarcoidosis: a Swedish register-based cohort study","volume":"56","author":"Rossides","year":"2020","journal-title":"Eur. Respir. J."},{"issue":"5","key":"10.1016\/j.jaut.2025.103397_bib99","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/resp.14001","article-title":"Infection risk in sarcoidosis patients treated with methotrexate compared to azathioprine: a retrospective 'target trial' emulated with Swedish real-world data","volume":"26","author":"Rossides","year":"2021","journal-title":"Respirology"},{"issue":"7","key":"10.1016\/j.jaut.2025.103397_bib100","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1001\/jamadermatol.2017.1162","article-title":"Efficacy and tolerance of anti-tumor necrosis factor alpha agents in cutaneous sarcoidosis: a French study of 46 cases","volume":"153","author":"Heidelberger","year":"2017","journal-title":"JAMA Dermatol"},{"issue":"2","key":"10.1016\/j.jaut.2025.103397_bib101","article-title":"COVID-19 infections in sarcoidosis: a prospective single center study of 886 sarcoidosis patients","volume":"38","author":"Baughman","year":"2021","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"issue":"4","key":"10.1016\/j.jaut.2025.103397_bib102","article-title":"Risk and outcome of COVID-19 infection in sarcoidosis patients: results of a self-reporting questionnaire","volume":"37","author":"Baughman","year":"2020","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"issue":"5","key":"10.1016\/j.jaut.2025.103397_bib103","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s00408-020-00392-9","article-title":"Moderate or severe impairment in pulmonary function is associated with mortality in sarcoidosis patients infected with SARS-CoV-2","volume":"198","author":"Morgenthau","year":"2020","journal-title":"Lung"},{"issue":"3","key":"10.1016\/j.jaut.2025.103397_bib104","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1183\/09031936.00226911","article-title":"Global burden of chronic pulmonary aspergillosis complicating sarcoidosis","volume":"41","author":"Denning","year":"2013","journal-title":"Eur. Respir. J."},{"issue":"2","key":"10.1016\/j.jaut.2025.103397_bib105","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s00408-011-9280-9","article-title":"Aspergillus lung disease in patients with sarcoidosis: a case series and review of the literature","volume":"189","author":"Pena","year":"2011","journal-title":"Lung"},{"issue":"4","key":"10.1016\/j.jaut.2025.103397_bib106","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1510\/icvts.2011.265553","article-title":"Surgery for aspergilloma: time trend towards improved results?","volume":"13","author":"Lejay","year":"2011","journal-title":"Interact. Cardiovasc. Thorac. Surg."},{"issue":"3 Pt 2","key":"10.1016\/j.jaut.2025.103397_bib107","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/0190-9622(90)70263-H","article-title":"Itraconazole therapy in aspergillosis: study in 49 patients","volume":"23","author":"Dupont","year":"1990","journal-title":"J. Am. Acad. Dermatol."},{"issue":"5","key":"10.1016\/j.jaut.2025.103397_bib108","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1378\/chest.12-1784","article-title":"A modern series of percutaneous intracavitary instillation of amphotericin B for the treatment of severe hemoptysis from pulmonary aspergilloma","volume":"143","author":"Kravitz","year":"2013","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.jaut.2025.103397_bib109","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1378\/chest.11-0324","article-title":"Increased risk of pulmonary embolism among US decedents with sarcoidosis from 1988 to 2007","volume":"140","author":"Swigris","year":"2011","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.jaut.2025.103397_bib110","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00408-019-00210-x","article-title":"Inpatient prevalence, expenditures, and comorbidities of sarcoidosis: nationwide inpatient sample 2013-2014","volume":"197","author":"Ungprasert","year":"2019","journal-title":"Lung"},{"issue":"5","key":"10.1016\/j.jaut.2025.103397_bib111","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1136\/thx.2010.134429","article-title":"Evidence for association between sarcoidosis and pulmonary embolism from 35-year record linkage study","volume":"66","author":"Crawshaw","year":"2011","journal-title":"Thorax"},{"issue":"3","key":"10.1016\/j.jaut.2025.103397_bib112","first-page":"243","article-title":"Drug-induced pneumonitis: the role of methotrexate","volume":"18","author":"Zisman","year":"2001","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"issue":"8","key":"10.1016\/j.jaut.2025.103397_bib113","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1093\/rheumatology\/kep046","article-title":"Sarcoid-like granulomatosis in patients treated with tumor necrosis factor blockers: 10 cases","volume":"48","author":"Daien","year":"2009","journal-title":"Rheumatology"},{"issue":"3","key":"10.1016\/j.jaut.2025.103397_bib114","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.chest.2018.03.056","article-title":"Drug-induced sarcoidosis-like reactions","volume":"154","author":"Chopra","year":"2018","journal-title":"Chest"}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841125000423?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841125000423?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T01:40:03Z","timestamp":1744249203000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841125000423"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":114,"alternative-id":["S0896841125000423"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2025.103397","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advanced pulmonary sarcoidosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2025.103397","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103397"}}